Quest Diagnostics, Inc., founded in 1967 and headquartered in Secaucus, New Jersey, is a leading provider of diagnostic information services, dedicated to empowering healthcare through innovative testing solutions. The company offers a comprehensive suite of laboratory tests, including routine and advanced testing across various medical disciplines, serving patients, clinicians, and healthcare organizations nationwide.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| DGX 2.80% 2031-06-30 USDQuest Diagnostics, Inc. | United States | 2031-06-30 | 2.800 | 4.39 |
| DGX 2.95% 2030-06-30 USDQuest Diagnostics, Inc. | United States | 2030-06-30 | 2.950 | 4.30 |
| DGX 3.45% 2026-06-01 USDQuest Diagnostics, Inc. | United States | 2026-06-01 | 3.450 | 4.10 |
| DGX 3.50% 2025-03-30 USDQuest Diagnostics, Inc. | United States | 2025-03-30 | 3.500 | 4.24 |
| DGX 4.20% 2029-06-30 USDQuest Diagnostics, Inc. | United States | 2029-06-30 | 4.200 | 3.82 |
| DGX 4.60% 2027-12-15 USDQuest Diagnostics, Inc. | United States | 2027-12-15 | 4.600 | 3.97 |
| DGX 4.63% 2029-12-15 USDQuest Diagnostics, Inc. | United States | 2029-12-15 | 4.625 | 4.17 |
| DGX 4.70% 2045-03-30 USDQuest Diagnostics, Inc. | United States | 2045-03-30 | 4.700 | 5.38 |
| DGX 5.00% 2034-12-15 USDQuest Diagnostics, Inc. | United States | 2034-12-15 | 5.000 | 4.80 |
| DGX 5.75% 2040-01-30 USDQuest Diagnostics, Inc. | United States | 2040-01-30 | 5.750 | 5.53 |
| DGX 6.40% 2033-11-30 USDQuest Diagnostics, Inc. | United States | 2033-11-30 | 6.400 | 4.71 |
| DGX 6.95% 2037-07-01 USDQuest Diagnostics, Inc. | United States | 2037-07-01 | 6.950 | 5.00 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Quest Diagnostics first began issuing bonds in the late 1990s to support its growth and expansion initiatives. A notable bond offering occurred in 2010, when the company issued $650 million in senior notes, used primarily to refinance existing debt. Currently, Quest Diagnostics' bonds yield approximately 4.25%, aligning closely with the industry average, and feature a diverse maturity profile. Recent news highlights the company's plans to maintain its balance sheet strength despite challenges in the healthcare sector, ensuring continued support for potential future bond offerings.